Skip to content

Medical Management of Caries in the Primary Dentition Using Silver Nitrate

Medical Management of Caries in the Primary Dentition Using Silver Nitrate: A Pilot Study

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02604134
Enrollment
122
Registered
2015-11-13
Start date
2014-07-31
Completion date
2018-08-21
Last updated
2019-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries

Keywords

silver nitrate, children, dental caries, medical management, quality of life

Brief summary

This pilot trial compares conventional restorations with a new strategy based on the medical management of caries using silver nitrate and fluoride varnish with no restorations.

Detailed description

This is a two-arm, parallel group, patient-randomized controlled pilot trial. Children with at least one primary tooth where caries extends into dentine. Children will be randomized and treated according to one of two treatment approaches;(1) conventional caries management with best practice prevention, or (2) medical management of caries using silver nitrate with best practice prevention. Baseline measures and outcome data (at treatment/review during two year follow-up) are assessed through direct reporting, clinical examination including blinded radiographic assessment, and child/parent questionnaires.

Interventions

PROCEDUREProphylaxis

A dental prophylaxis is a cleaning procedure performed to thoroughly clean the teeth. Prophylaxis is an important dental treatment for halting the progression of periodontal disease and gingivitis.

DRUGFluoride varnish

Fluoride varnish is a highly concentrated form of fluoride which is applied to the tooth's surface, by a dentist, dental hygienist or other health care professional, as a type of topical fluoride therapy.

a small amount will be applied to the tooth via a cotton applicator. Silver nitrate is a colorless, odorless, transparent solution used as an escharotic, dehydrating and sclerosing agent.

Sponsors

Delta Dental of Iowa
CollaboratorOTHER
Arwa Owais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

the radiographic progression of caries is assessed by a masked investigator

Eligibility

Sex/Gender
ALL
Age
2 Years to 11 Years
Healthy volunteers
Yes

Inclusion criteria

* Presense of one or more cavitated carious lesions in the primary dentition, extending into dentin but not encroaching on the pulp. * Absense of any spontaneous or elicited pain due to caries, or signs of pulpal infection in response to any of the carious lesions in the primary dentition to be included in the study

Exclusion criteria

* Hereditary developmental defects of the teeth such as Amelogenesis Imperfecta and Dentinogenesis Imperfecta * Medical conditions that prevent treatment of the child in the outpatient clinic. These conditions include severe bleeding disorders, cardiac problems and mental disabilities that prevent child from communication with the research team. * Known allergy/sensitivity to any of the dental materials.

Design outcomes

Primary

MeasureTime frameDescription
Change in baseline Caries Experience and activity (Incidence of caries in primary teeth)through study completion, for 2 yearsDetailed measurements of caries experience will be recorded at baseline and annual caries examination using EC4

Secondary

MeasureTime frameDescription
Caries activity in primary teeththrough study completion, for 2 yearsDetailed measurements of caries activity will be recorded at baseline and annual caries examination using Nyvad scores.

Other

MeasureTime frameDescription
Pain (toothache) and/or infection in primary teeththrough study completion, for 2 yearsAssessments for pain from toothache will be made at each visit throughout the patient's participation in the trial using the Dental Discomfort Questionnaire completed by the parents.
Patient quality of lifethrough study completion, for 2 yearsQuality of life will be assessed through direct reporting by parents and children about pain and related activities
Cost-effectivenessthrough study completion, for 2 yearsCost-effectiveness for both groups will be calculated and compared
Acceptability of treatment strategies by parents and childrenthrough study completion, for 2 yearsAcceptability is checked throughout the whole period of the study every time the patient comes in for a recall

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026